» Articles » PMID: 22933981

Lower Tumour Burden and Better Overall Survival in Melanoma Patients with Regional Lymph Node Metastases and Negative Preoperative Ultrasound

Overview
Journal Radiol Oncol
Publisher Sciendo
Specialties Oncology
Radiology
Date 2012 Aug 31
PMID 22933981
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The purpose of the study was to evaluate the ability of ultrasound (US) and fine needle aspiration biopsy (FNAB) in reducing the number of melanoma patients requiring a sentinel node biopsy (SNB); to compare the amount of metastatic disease in regional lymph nodes in SNB candidates with clinically uninvolved lymph nodes and of those with US uninvolved lymph nodes; and to compare the overall survival (OS) of both groups.

Methods: Between 2000 and 2007, a SNB was successfully performed in 707 patients with melanoma. The preoperative US of the regional lymph node basins was performed in 405 SNB candidates. In 14 of these patients, the US-guided FNAB was positive and they proceeded directly to lymph node dissection. In 391 patients, the preoperative US was either negative (343 patients) or suspicious (48 patients) (US group). In the remaining 316 patients the preoperative US was not performed (non-US group).

Results: The proportion of macrometastatic sentinel lymph nodes (SN), number of metastatic lymph nodes per patient and proportion of nonsentinel lymph node metastases were found to be lower in the US group compared to the non-US group. The smaller tumour burden of the US group was reflected in a significantly better OS of patients with SN metastases.

Conclusions: The preoperative US of regional lymph nodes spares some patients with melanoma from undergoing a SNB. Patients with regional metastases and a negative preoperative US have a significantly lower tumour burden in comparison to those with clinically negative lymph nodes, which is also reflected in a better OS.

Citing Articles

Lymph Node Invasion by Melanoma Cells Is Not Required for the Induction of Incomplete Differentiation by Tumor-Specific CD8+ T Cells.

Hargadon K, Goodloe 3rd T, Woodall 2nd S Cancer Rep (Hoboken). 2025; 8(2):e70145.

PMID: 39930625 PMC: 11810983. DOI: 10.1002/cnr2.70145.


Gamma probe and ultrasound guided fine needle aspiration cytology of the sentinel node (GULF) trial - overview of the literature, pilot and study protocol.

Oude Ophuis C, Koppert L, de Monye C, van Deurzen C, Koljenovic S, van Akkooi A BMC Cancer. 2017; 17(1):258.

PMID: 28403815 PMC: 5389093. DOI: 10.1186/s12885-017-3236-2.


Clinical utilities and biological characteristics of melanoma sentinel lymph nodes.

Han D, Thomas D, Zager J, Pockaj B, White R, Leong S World J Clin Oncol. 2016; 7(2):174-88.

PMID: 27081640 PMC: 4826963. DOI: 10.5306/wjco.v7.i2.174.


The role of ultrasound and ultrasound-guided fine needle aspiration biopsy of lymph nodes in patients with skin tumours.

Solivetti F, Elia F, Santaguida M, Guerrisi A, Visca P, Cercato M Radiol Oncol. 2014; 48(1):29-34.

PMID: 24587776 PMC: 3908844. DOI: 10.2478/raon-2013-0084.


Inguinal or inguino-iliac/obturator lymph node dissection after positive inguinal sentinel lymph node in patients with cutaneous melanoma.

Glumac N, Hocevar M, Zadnik V, Snoj M Radiol Oncol. 2012; 46(3):258-64.

PMID: 23077465 PMC: 3472950. DOI: 10.2478/v10019-012-0041-z.

References
1.
Cochran A, Wen D, Huang R, Wang H, Elashoff R, Morton D . Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node. Mod Pathol. 2004; 17(7):747-55. DOI: 10.1038/modpathol.3800117. View

2.
Balch C, Gershenwald J, Soong S, Thompson J, Ding S, Byrd D . Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol. 2010; 28(14):2452-9. PMC: 2982783. DOI: 10.1200/JCO.2009.27.1627. View

3.
Reeves M, Delgado R, Busam K, Brady M, Coit D . Prediction of nonsentinel lymph node status in melanoma. Ann Surg Oncol. 2003; 10(1):27-31. DOI: 10.1245/aso.2003.03.020. View

4.
Hocevar M, Bracko M, Pogacnik A, Vidergar-Kralj B, Besic N, Zgajnar J . Role of imprint cytology in the intraoperative evaluation of sentinel lymph nodes for malignant melanoma. Eur J Cancer. 2003; 39(15):2173-8. DOI: 10.1016/s0959-8049(03)00453-2. View

5.
van Akkooi A, Spatz A, Eggermont A, Mihm M, Cook M . Expert opinion in melanoma: the sentinel node; EORTC Melanoma Group recommendations on practical methodology of the measurement of the microanatomic location of metastases and metastatic tumour burden. Eur J Cancer. 2009; 45(16):2736-42. DOI: 10.1016/j.ejca.2009.08.015. View